Cargando…
“Derived Multiple Allogeneic Protein Paracrine Signaling (d-MAPPS)” Enhances T Cell-Driven Immune Response to Murine Mammary Carcinoma
Breast cancer is considered refractory to immunotherapy. Accordingly, there is an urgent need for the therapeutic use of new immunostimulatory agents which would enhance antitumor immune response against breast cancer cells. “Derived Multiple Allogeneic Protein Paracrine Signaling (d-MAPPS)” is a bi...
Autores principales: | Harrell, Carl Randall, Pavlovic, Dragica, Miloradovic, Dragana, Stojanovic, Milica Dimitrijevic, Djonov, Valentin, Volarevic, Vladislav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217617/ https://www.ncbi.nlm.nih.gov/pubmed/35757015 http://dx.doi.org/10.1155/2022/3655595 |
Ejemplares similares
-
Molecular and Cellular Mechanisms Responsible for Beneficial Effects of Mesenchymal Stem Cell-Derived Product “Exo-d-MAPPS” in Attenuation of Chronic Airway Inflammation
por: Harrell, Carl Randall, et al.
Publicado: (2020) -
Therapeutic potential of mesenchymal stem cells in the treatment of acute liver failure
por: Harrell, Carl Randall, et al.
Publicado: (2022) -
The Effects of Mesenchymal Stem Cells on Antimelanoma Immunity Depend on the Timing of Their Administration
por: Miloradovic, Dragana, et al.
Publicado: (2020) -
Mesenchymal Stem Cell-Derived Exosomes as New Remedy for the Treatment of Neurocognitive Disorders
por: Harrell, Carl Randall, et al.
Publicado: (2021) -
Therapeutic Potential of Exosomes Derived from Adipose Tissue-Sourced Mesenchymal Stem Cells in the Treatment of Neural and Retinal Diseases
por: Harrell, Carl Randall, et al.
Publicado: (2022)